Abstract:BACKGROUND: N6-methyladenosine (m6A) modification holds an important position in tumorigenesis and metastasis because it can change gene expression and even function in multiple levels including RNA splicing, stability, translocation and translation. In present study, we aim to conducted comprehensive investigation on m6A RNA methylation regulators and m6A-related genes in pancreatic cancer and their association with survival time.METHODS: Based on Univariate Cox regression analysis, protein-protein interaction analysis, LASSO Cox regression, a risk prognostic model, STRING, Spearman and consensus clustering analysis, data from The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) database was used to analyze 15 m6A RNA methylation regulators that were widely reported and 1,393 m6A-related genes in m6Avar.RESULTS: We found that 283 candidate m6A RNA methylation-related genes and 4 m6A RNA methylation regulatory factors, including RNA binding motif protein 15 (RBM15), methyltransferase like 14 (METTL14), fat mass and obesity-associated protein (FTO), and α-ketoglutarate-dependent dioxygenase AlkB homolog 5 (ALKBH5), differed significantly among different stages of the American Joint Committee on Cancer (AJCC) staging system. Protein-protein interaction analysis indicated epidermal growth factor receptor (EGFR), plectin-1 (PLEC), BLM RecQ like helicase (BLM), and polo like kinase 1 (PLK1) were closely related to other genes and could be considered as hub genes in the network. The results of LASSO Cox regression and the risk prognostic model indicated that AJCC stage, stage T and N, KRAS mutation status and x8q23.3 CNV fragment mutation differed significantly between the high-risk and the low-risk subgroups. The AUCs of 1 to 5 years after surgery were all more than 0.7 and increased year by year. Finally, we found KRAS mutation status and AJCC stage differed significantly among these groups after TCGA samples divided into subgroups with k=7. Moreover, we identified four m6A RNA methylation related genes expressed significantly differently among these seven subgroups, including collagen type VII alpha 1 chain (COL7A1), branched chain amino acid transaminase 1 (BCAT1), zinc finger protein 596 (ZNF596), and PLK1.CONCLUSIONS: Our study systematically analyzed the m6A RNA methylation related genes, including expression, protein-protein interaction, potential function, and prognostic value and provides important clues to further research on the function of RNA m6A methylation and its related genes in pancreatic cancer.

Additional File 2 of Genome-wide Identification and Characterization of Circular RNA M6a Modification in Pancreatic Cancer

Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer

Additional File 1 of Genetic Alterations and Functional Networks of M6a RNA Methylation Regulators in Pancreatic Cancer Based on Data Mining

Additional File 1: of Comprehensive Characterization of Circular RNAs in ~â1000 Human Cancer Cell Lines

N6-methyladenosine Modification of Circnsun2 Facilitates Cytoplasmic Export and Stabilizes HMGA2 to Promote Colorectal Liver Metastasis.

Abstract 4827: N6-Methyladenosine Modification of LINC00901 Promotes Pancreatic Cancer Progression

Additional File 1 of CircSTX6 Promotes Pancreatic Ductal Adenocarcinoma Progression by Sponging Mir-449B-5p and Interacting with CUL2

Additional File 4 of LncRNA-PACERR Induces Pro-Tumour Macrophages Via Interacting with Mir-671-3p and M6a-Reader IGF2BP2 in Pancreatic Ductal Adenocarcinoma

Additional File 3 of FUS-induced Circrhobtb3 Facilitates Cell Proliferation Via Mir-600/Nacc1 Mediated Autophagy Response in Pancreatic Ductal Adenocarcinoma

Circular RNA Expression Profile and M6a Modification Analysis in Poorly Differentiated Adenocarcinoma of the Stomach.

Additional File 4 of the LINC00623/NAT10 Signaling Axis Promotes Pancreatic Cancer Progression by Remodeling Ac4c Modification of Mrna

Comprehensive Analyses of Molecular Features, Prognostic Values, and Regulatory Functionalities of M6a-Modified Long Non-Coding RNAs in Lung Adenocarcinoma.

Additional File 19 of Single-cell RNA-seq Reveals the Genesis and Heterogeneity of Tumor Microenvironment in Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant-Cells

M6a Modification of Circhps5 and Hepatocellular Carcinoma Progression Through HMGA2 Expression

Additional File 14 of M6a Eraser FTO Impairs Gemcitabine Resistance in Pancreatic Cancer Through Influencing NEDD4 Mrna Stability by Regulating the PTEN/PI3K/AKT Pathway

Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer

Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival

Additional File 4: of Translation of the Circular RNA Circî˛-Catenin Promotes Liver Cancer Cell Growth Through Activation of the Wnt Pathway

Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population

Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer

Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer